SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 85 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2013. The put-call ratio across all filers is 0.34 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,000 | -98.9% | 21,169 | -99.1% | 0.00% | – |
| Q1 2016 | $568,000 | -34.0% | 2,366,650 | -3.2% | 0.00% | – |
| Q4 2015 | $861,000 | -88.5% | 2,445,933 | -43.3% | 0.00% | -100.0% |
| Q3 2015 | $7,501,000 | -18.4% | 4,311,183 | +4.6% | 0.00% | 0.0% |
| Q2 2015 | $9,187,000 | +45.2% | 4,119,691 | +26.3% | 0.00% | 0.0% |
| Q1 2015 | $6,329,000 | -23.2% | 3,262,459 | +4.9% | 0.00% | 0.0% |
| Q4 2014 | $8,239,000 | -2.9% | 3,109,116 | +10.3% | 0.00% | 0.0% |
| Q3 2014 | $8,484,000 | -17.9% | 2,818,656 | +11.5% | 0.00% | -33.3% |
| Q2 2014 | $10,335,000 | -2.2% | 2,526,884 | +3.1% | 0.00% | 0.0% |
| Q1 2014 | $10,564,000 | -12.1% | 2,450,940 | +6.9% | 0.00% | -25.0% |
| Q4 2013 | $12,016,000 | -0.1% | 2,293,143 | +20.3% | 0.00% | 0.0% |
| Q3 2013 | $12,026,000 | +44.3% | 1,905,878 | +14.1% | 0.00% | +33.3% |
| Q2 2013 | $8,332,000 | – | 1,669,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
| Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
| Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
| CAXTON CORP | 52,000 | $116,000 | 0.12% |
| Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
| Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
| SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
| Roundview Capital LLC | 29,100 | $65,000 | 0.02% |